Madrigal Pharmaceuticals, Inc. - MDGL
About Gravity Analytica
Recent News
- 09.08.2025 - Morgan Stanley 23rd Annual Global Health Care Conference
- 09.08.2025 - Morgan Stanley 23rd Annual Global Health Care Conference
- 09.04.2025 - Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
- 09.04.2025 - Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
- 09.04.2025 - Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
- 09.03.2025 - Madrigal Pharmaceuticals to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
- 09.03.2025 - Madrigal Pharmaceuticals to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
- 09.03.2025 - Madrigal Pharmaceuticals to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
- 08.21.2025 - Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
- 08.21.2025 - Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Recent Filings
- 08.29.2025 - 144 Report of proposed sale of securities
- 08.21.2025 - 144 Report of proposed sale of securities
- 08.21.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.20.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.20.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.20.2025 - 144 Report of proposed sale of securities